| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.35 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.27 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.23 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.18 | 0.4 |